Optimal Implantable Cardioverter Defibrillator (ICD) Generator Replacement

被引:6
|
作者
Khojandi, Anahita [1 ]
Maillart, Lisa M. [1 ]
Prokopyev, Oleg A. [1 ]
Roberts, Mark S. [2 ]
Brown, Timothy [3 ]
Barrington, William W. [4 ]
机构
[1] Univ Pittsburgh, Dept Ind Engn, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Dept Hlth Policy & Management, Pittsburgh, PA 15261 USA
[3] Medtronic, Minneapolis, MN 55432 USA
[4] Univ Pittsburgh, Med Ctr, Inst Heart & Vasc, Pittsburgh, PA 15213 USA
基金
美国国家科学基金会;
关键词
optimal replacement; Markov decision processes; threshold policy; CUMULATIVE DAMAGE MODELS; FOLLOW-UP; DEVICE ADVISORIES; CLINICAL-PRACTICE; RISK-FACTORS; LONGEVITY; INFECTIONS; PACEMAKERS; INSIGHTS; DATABASE;
D O I
10.1287/ijoc.2013.0586
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
Implantable cardioverter defibrillators ( ICDs) include small, battery-powered generators, the longevity of which depends on a patient's rate of consumption. Generator replacement, however, involves risks, including death. Hence, a trade-off exists between prematurely exposing the patient to these risks and allowing for the possibility that the device is unable to deliver therapy when needed. Currently, replacements are performed using a one-size-fits-all approach. Here, we develop a Markov decision process model to determine patient-specific optimal replacement policies as a function of patient age and the remaining battery capacity. We analytically establish that the optimal policy is of threshold-type in the remaining capacity, but not necessarily in patient age. Based on clinical data, we conduct a large computational study that suggests that under the optimal policy, patients undergoing initial implantation at age 30-40, 41-60, and 61-80 see an approximate decrease in the total expected number of replacements of 8%-14%, 8%-15% and 8%-19%, respectively, while achieving the same or greater expected lifetime.
引用
收藏
页码:599 / 615
页数:17
相关论文
共 50 条
  • [31] Subcutaneous implantable cardioverter-defibrillator (S-ICD)
    Lobodzinski, S. Suave
    CARDIOLOGY JOURNAL, 2011, 18 (03) : 326 - 331
  • [32] Memory functioning following implantable cardioverter defibrillator (ICD) surgery
    Fuller, CJ
    Frizelle, DJ
    Wang, M
    Kaye, G
    BRITISH JOURNAL OF ANAESTHESIA, 2004, 93 (03) : 491P - 492P
  • [33] PATIENTS' EXPERIENCE OF REMOTE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) INTERROGATION
    Groarke, J.
    Beirne, A.
    Buckley, U.
    Sugrue, D.
    Keelan, T.
    Galvin, J.
    O'Neill, J.
    Mahon, N.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2010, 179 : S408 - S408
  • [34] MORTALITY DETERMINANTS IN ICD (IMPLANTABLE CARDIOVERTER DEFIBRILLATOR) IMPLANTED PATIENTS
    Edem, E.
    Aslan, O.
    Goldeli, O.
    Guneri, S.
    Ozpelit, E.
    Aytemiz, F.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 163 : S205 - S206
  • [35] MY APPROACH to the patient with an infected implantable cardioverter defibrillator (ICD)
    Curtis, Anne B.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2017, 27 (08) : 587 - 588
  • [36] Predictors of panic for patients with implantable cardioverter-defibrillator (ICD)
    Lang, S.
    Becker, R.
    Herzog, W.
    Hartmann, M.
    Loewe, B.
    PSYCHOTHERAPIE PSYCHOSOMATIK MEDIZINISCHE PSYCHOLOGIE, 2008, 58 (02) : 95 - 95
  • [37] Candida albicans endocarditis in a patient with an implantable cardioverter defibrillator (ICD)
    Eguibar-Villimar, Itziar
    Manuel Porres-Aracama, Jose
    Azcarate-Ayerdi, Begona
    Salaberri Udabe, Ruth
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2015, 33 (03): : 213 - 214
  • [38] THE STUDY ON ANXIETY DISORDERS IN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) PATIENTS
    Ranjbar, F.
    Akbarzadeh, F.
    Ghaemian, N.
    EUROPEAN PSYCHIATRY, 2010, 25
  • [39] THE IMPLANTABLE CARDIOVERTER/DEFIBRILLATOR (ICD) - DEVELOPMENT TO PRESENT AND PERSPECTIVES FOR THE FUTURE
    BRACHMANN, J
    HILBEL, T
    SCHOLS, W
    BEYER, T
    SCHWEIZER, M
    STERNS, L
    KAROLYI, L
    MELICHERCIK, J
    FREIGANG, KD
    KUBLER, W
    HERZ, 1994, 19 (05) : 246 - 250
  • [40] A CRITICAL-APPRAISAL OF INDICATIONS FOR THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD)
    CANNOM, DS
    CLINICAL CARDIOLOGY, 1992, 15 (05) : 369 - 372